Over the last 10 years, West Pharmaceutical Services stock has attracted buying interest at this level 7 times and has ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

Lexicon Pharmaceuticals (LXRX) has priced its public offering of 32M shares of its common stock, par value $0.001, at $1.30 per share to raise $41.6M. The firm has granted the underwriters a 30-day ...

The government has imposed a Minimum Import Price fixed at ₹2,216/kg for Penicillin G and is expected to provide a ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...

Clinical-stage biopharmaceutical company Corvus Pharmaceuticals (CRVS) priced an upsized underwritten public offering of .9M ...

A Wells Fargo analyst cut his price target on Ultragenyx stock, though it still implies significant upside from yesterday's closing price. Ultragenyx reported yesterday that two Phase 3 studies failed ...

Alnylam Pharmaceuticals (ALNY) has recently drawn attention after a period of weaker share performance, with the stock down about 15% over the past month and roughly 26% over the past 3 months. See ...

The stock's 14-day relative strength index (RSI) is 30.63. For the uninitiated, a level above 70 is considered overbought or ...

Ligand Pharmaceuticals (LGND) is a royalty investor in late-stage biopharma, with revenue and EPS growth driven by a robust portfolio.